AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

ETOMIDATE

5 registrations across 4 African markets— 4 active

Markets with ETOMIDATE

🇿🇦South Africa
2 registrations
2 active
🇲🇦Morocco
1 registration
1 active
🇹🇳Tunisia
1 registration
0 active
🇿🇼Zimbabwe
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
HYPNOMIDATE
INJECTABLE; INJECTION
🇿🇼ZimbabwePIRAMAL CRITICAL CARE SOUTH AFRICA (PTY) LTDactiveDec 2027
HYPNOMIDATE
Solution injectable / 2 mg/ml
🇹🇳TunisiaPiramal Critical Care B.V.expiredOct 2020
HYPNOMIDATE🇿🇦South AfricaPiramal Critical Care South Africa (Pty) LtdactiveJan 1900
B. BRAUN ETOMIDATE 2 mg/ml🇿🇦South AfricaB Braun Medical (Pty) LtdactiveJan 1900
HYPNOMIDATE
SOLUTION INJECTABLE
🇲🇦Morocco—active—

ETOMIDATE in Africa — Regulatory Overview

ETOMIDATE is registered across 4 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Tunisia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 5 registrations, 4 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.